Egypt at a glance
- Population
- 118.4 million 2025
- Life expectancy at birth
- 71.8 years, 2024
- People aged 65 and over
- 5.3 % of people, 2025
- Health spending per person
- 141 US$ per person, 2023
- Doctors
- 0.67 per 1,000 people, 2020
Updated
Reviewed by Chandani Patel
Egypt Sleep Aid Supplements Market Industry Trends and Forecast to 2034: Segmented by (Ingredient, Form, Distribution Channel, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$25.2 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $19.1 Mn | — | — |
| 2025 (base) | $20.9 Mn | +$1.8 Mn | — |
| 2026 (forecast) | $22.8 Mn | +$1.9 Mn | +9.2% |
| 2027 (forecast) | $24.9 Mn | +$2.1 Mn | +19.2% |
| 2028 (forecast) | $27.2 Mn | +$2.3 Mn | +30.2% |
| 2029 (forecast) | $29.7 Mn | +$2.5 Mn | +42.2% |
| 2030 (forecast) | $32.4 Mn | +$2.7 Mn | +55.3% |
| 2031 (forecast) | $35.4 Mn | +$3.0 Mn | +69.6% |
| 2032 (forecast) | $38.6 Mn | +$3.3 Mn | +85.2% |
| 2033 (forecast) | $42.2 Mn | +$3.6 Mn | +102.2% |
| 2034 (forecast) | $46.1 Mn | +$3.9 Mn | +120.8% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $20.9 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $46.1 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 9.2% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Ingredient, form and distribution channel (see all) |
| Key players | Natrol LLC, Olly (Unilever), Nature Made, ZzzQuil (Procter & Gamble), Pharmavite LLC (see all) |
| Regulator in Egypt | EDA and EDA and NFSASource: Egyptian Drug Authority. Checked 14 Nov 2026.Source: Egyptian Drug Authority. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Sleep aid supplements contain melatonin, magnesium, herbs and other ingredients marketed to help people fall and stay asleep.
Key segments of the sleep Aid Supplements market include ingredient (Melatonin, Magnesium and Valerian) and form (Gummies, Tablets and Drinks).
Growing interest in prevention, social media trends, ageing consumers, sports nutrition going mainstream and easy online shopping are driving the sleep Aid Supplements market.
Personalised nutrition, clinically tested ingredients and new formats such as gummies and drinks give the sleep Aid Supplements market strong room to grow.
Mixed scientific evidence, quality and safety concerns, strict health-claim rules and price competition hold back the sleep Aid Supplements market.
The sleep Aid Supplements market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medicines are registered with the Egyptian Drug Authority (EDA), set up in 2019.[1] Vitamins and herbal products sold as complementary medical products are registered with the Egyptian Drug Authority (EDA), while supplements sold as food come under the National Food Safety Authority (NFSA).[1]
[1] Egyptian Drug Authority. Checked 14 Nov 2026.
Food and supplement rules, labelling and health-claim regulations govern sleep Aid Supplements products. Authorities such as the US FDA, EFSA and national food safety bodies set what can be sold and claimed in Egypt.
What doctors and scientists are doing in Sleep Aid Supplements right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.
From our blog
Egypt · 5 shared keywords
Egypt · 3 shared keywords
Egypt · 2 shared keywords
Egypt · 2 shared keywords
Egypt · 2 shared keywords
Egypt · 2 shared keywords
Medical Devices · Egypt
Digital Health · Egypt
Public Health · Egypt
Public Health · Egypt
Medical Devices · Egypt
Pharmaceuticals · Egypt